Related Experiment Video
Updated: Jul 22, 2026
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
High-Throughput Screening Identifies miR-451 as a Pleiotropic Modulator That Suppresses Gastric Cancer Metastasis
Wendao You1, Liang Xu1, Xing Zhang1
11 Department of Gastroenterology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Abstract:
MicroRNAs (miRNAs) are globally dysregulated in human carcinomas. However, the specific miRNAs that mediate gastric cancer metastasis have not been identified. We identified 100 miRNAs that are dysregulated in gastric cancer and used a self-assembled cell microarray method to systematically evaluate their capacity to regulate cell migration. MiR-451, which is down-regulated in human gastric cancer samples, potently modulated multiple metastatic phenotypes including cell migration, invasion, proliferation, and epithelial-mesenchymal transition. These effects were achieved via down-regulation of the miR-451 target gene, ERK2. These findings provide new insight into the physiological effects of and potential therapeutic uses for miRNAs in gastric cancer.
Insights
MicroRNAs (miRNAs) are key in gastric cancer. Researchers found miR-451, a down-regulated miRNA, inhibits gastric cancer metastasis by targeting ERK2, offering potential therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) show global dysregulation in human carcinomas.
- Specific miRNAs mediating gastric cancer metastasis remain largely unidentified.
Purpose of the Study:
- To identify specific microRNAs regulating gastric cancer metastasis.
- To investigate the functional role of dysregulated miRNAs in gastric cancer progression.
Main Methods:
- Systematic evaluation of 100 dysregulated miRNAs using a self-assembled cell microarray.
- Assessment of miRNA impact on cell migration, invasion, proliferation, and epithelial-mesenchymal transition.
- Identification of miRNA target genes, specifically ERK2 for miR-451.
Main Results:
- MiR-451 was identified as a significantly down-regulated miRNA in gastric cancer samples.
- Down-regulation of miR-451 potently modulated multiple metastatic phenotypes.
- MiR-451 exerted its effects through the down-regulation of its target gene, ERK2.
Conclusions:
- MiR-451 plays a crucial role in suppressing gastric cancer metastasis.
- ERK2 is a key target gene mediating the anti-metastatic effects of miR-451.
- These findings highlight the potential of miRNAs, particularly miR-451, as therapeutic targets in gastric cancer treatment.
